Drug
Cabergoline
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Mitral Valve Incompetence | 101 | 39.0 | 39.8 | signal |
| 2 | Obesity | 74 | 20.2 | 20.5 | signal |
| 3 | Knee Arthroplasty | 85 | 17.7 | 18.0 | signal |
| 4 | Body Temperature Decreased | 36 | 15.8 | 15.9 | signal |
| 5 | Adrenal Insufficiency | 40 | 14.5 | 14.6 | signal |
| 6 | Schizophrenia | 37 | 13.2 | 13.3 | signal |
| 7 | Blood Pressure Systolic Increased | 56 | 12.4 | 12.6 | signal |
| 8 | Delusion | 44 | 12.3 | 12.4 | signal |
| 9 | Cardiomegaly | 34 | 11.9 | 12.0 | signal |
| 10 | Lower Respiratory Tract Infection | 119 | 11.4 | 11.7 | signal |
| 11 | Sleep Apnoea Syndrome | 50 | 11.4 | 11.5 | signal |
| 12 | Drug Resistance | 62 | 10.5 | 10.6 | signal |
| 13 | Arthropathy | 134 | 10.4 | 10.7 | signal |
| 14 | Neoplasm | 27 | 10.2 | 10.2 | signal |
| 15 | Cholelithiasis | 76 | 10.1 | 10.2 | signal |
| 16 | Gastrointestinal Pain | 25 | 9.9 | 10.0 | signal |
| 17 | Neoplasm Progression | 78 | 9.6 | 9.8 | signal |
| 18 | Brain Neoplasm | 20 | 9.4 | 9.5 | signal |
| 19 | Nocturia | 23 | 8.2 | 8.3 | signal |
| 20 | Blood Iron Decreased | 22 | 8.1 | 8.1 | signal |
| 21 | Nerve Injury | 20 | 7.8 | 7.8 | signal |
| 22 | Neuroleptic Malignant Syndrome | 21 | 7.7 | 7.7 | signal |
| 23 | Hepatic Steatosis | 32 | 7.5 | 7.5 | signal |
| 24 | Thyroid Disorder | 26 | 7.3 | 7.4 | signal |
| 25 | Irritable Bowel Syndrome | 35 | 7.1 | 7.2 | signal |
| 26 | Pulmonary Hypertension | 34 | 7.1 | 7.1 | signal |
| 27 | Muscle Rigidity | 19 | 6.9 | 6.9 | signal |
| 28 | Drug Abuse | 132 | 6.8 | 7.0 | signal |
| 29 | Hallucination, Visual | 33 | 6.8 | 6.9 | signal |
| 30 | Hyperglycaemia | 56 | 6.7 | 6.8 | signal |
| 31 | Hallucination, Auditory | 24 | 6.5 | 6.6 | signal |
| 32 | Needle Issue | 43 | 6.5 | 6.6 | signal |
| 33 | Blood Urea Increased | 24 | 6.2 | 6.2 | signal |
| 34 | Intentional Product Misuse | 121 | 6.0 | 6.2 | signal |
| 35 | Body Height Decreased | 15 | 6.0 | 6.0 | signal |
| 36 | Inappropriate Antidiuretic Hormone Secretion | 14 | 6.0 | 6.0 | signal |
| 37 | Restless Legs Syndrome | 25 | 6.0 | 6.0 | signal |
| 38 | Spinal Pain | 16 | 5.9 | 5.9 | signal |
| 39 | Blood Potassium Increased | 22 | 5.9 | 5.9 | signal |
| 40 | Pulmonary Mass | 20 | 5.8 | 5.9 | signal |
| 41 | Limb Discomfort | 40 | 5.6 | 5.6 | signal |
| 42 | Deformity | 12 | 5.6 | 5.6 | signal |
| 43 | Pleural Effusion | 77 | 5.5 | 5.6 | signal |
| 44 | Lymphocyte Count Decreased | 22 | 5.4 | 5.4 | signal |
| 45 | Blood Triglycerides Increased | 22 | 5.4 | 5.4 | signal |
| 46 | Dementia | 34 | 5.3 | 5.3 | signal |
| 47 | Breast Pain | 13 | 5.3 | 5.3 | signal |
| 48 | Blood Pressure Fluctuation | 29 | 5.2 | 5.3 | signal |
| 49 | Blindness | 49 | 5.2 | 5.3 | signal |
| 50 | Head Discomfort | 21 | 5.2 | 5.2 | signal |
| 51 | Subarachnoid Haemorrhage | 12 | 5.1 | 5.1 | signal |
| 52 | Hypoglycaemia | 57 | 5.1 | 5.1 | signal |
| 53 | Lung Neoplasm Malignant | 48 | 5.0 | 5.1 | signal |
| 54 | Oral Pain | 26 | 5.0 | 5.0 | signal |
| 55 | Glycosylated Haemoglobin Increased | 29 | 5.0 | 5.0 | signal |
| 56 | Mass | 16 | 5.0 | 5.0 | signal |
| 57 | Affect Lability | 11 | 4.9 | 4.9 | signal |
| 58 | Heart Rate Decreased | 40 | 4.9 | 4.9 | signal |
| 59 | Inflammation | 58 | 4.9 | 4.9 | signal |
| 60 | Mucosal Inflammation | 29 | 4.8 | 4.8 | signal |
| 61 | Caesarean Section | 13 | 4.8 | 4.8 | signal |
| 62 | Hypophagia | 28 | 4.8 | 4.8 | signal |
| 63 | Heart Rate Irregular | 25 | 4.8 | 4.8 | signal |
| 64 | Mania | 18 | 4.8 | 4.8 | signal |
| 65 | Eating Disorder | 23 | 4.7 | 4.7 | signal |
| 66 | Ear Discomfort | 11 | 4.7 | 4.7 | signal |
| 67 | Faeces Discoloured | 23 | 4.6 | 4.6 | signal |
| 68 | Spinal Disorder | 10 | 4.6 | 4.6 | signal |
| 69 | Haematocrit Decreased | 21 | 4.6 | 4.6 | signal |
| 70 | Urinary Incontinence | 31 | 4.5 | 4.6 | signal |
| 71 | Pulmonary Fibrosis | 20 | 4.5 | 4.6 | signal |
| 72 | Blood Creatine Phosphokinase Increased | 30 | 4.4 | 4.5 | signal |
| 73 | Maternal Exposure During Pregnancy | 90 | 4.4 | 4.5 | signal |
| 74 | Psychomotor Hyperactivity | 17 | 4.4 | 4.4 | signal |
| 75 | Diabetes Mellitus | 78 | 4.4 | 4.5 | signal |
| 76 | Ligament Sprain | 10 | 4.4 | 4.4 | signal |
| 77 | Dyskinesia | 41 | 4.4 | 4.4 | signal |
| 78 | Abdominal Discomfort | 168 | 4.4 | 4.5 | signal |
| 79 | Bipolar Disorder | 11 | 4.4 | 4.4 | signal |
| 80 | Injection Site Induration | 13 | 4.4 | 4.4 | signal |
| 81 | Product Administration Error | 20 | 4.3 | 4.4 | signal |
| 82 | Blood Glucose Fluctuation | 11 | 4.3 | 4.3 | signal |
| 83 | Blood Potassium Decreased | 30 | 4.3 | 4.3 | signal |
| 84 | Psychotic Disorder | 29 | 4.3 | 4.3 | signal |
| 85 | Paranoia | 17 | 4.3 | 4.3 | signal |
| 86 | Bone Disorder | 18 | 4.2 | 4.3 | signal |
| 87 | Red Blood Cell Count Decreased | 27 | 4.1 | 4.1 | signal |
| 88 | Hypothyroidism | 30 | 4.1 | 4.1 | signal |
| 89 | Dizziness Postural | 9 | 4.1 | 4.1 | signal |
| 90 | Decreased Activity | 10 | 4.0 | 4.1 | signal |
| 91 | Depressed Mood | 49 | 4.0 | 4.1 | signal |
| 92 | Premature Baby | 28 | 4.0 | 4.0 | signal |
| 93 | Dystonia | 18 | 4.0 | 4.0 | signal |
| 94 | Parkinsonism | 9 | 4.0 | 4.0 | signal |
| 95 | Osteoarthritis | 39 | 4.0 | 4.0 | signal |
| 96 | Drug Interaction | 144 | 3.9 | 4.0 | signal |
| 97 | Abortion Spontaneous | 36 | 3.9 | 3.9 | signal |
| 98 | Hallucination | 67 | 3.9 | 3.9 | signal |
| 99 | Personality Change | 8 | 3.7 | 3.7 | signal |
| 100 | Flank Pain | 8 | 3.7 | 3.7 | signal |
| 101 | Osteoporosis | 35 | 3.7 | 3.7 | signal |
| 102 | Blood Glucose Decreased | 40 | 3.6 | 3.6 | signal |
| 103 | Head Injury | 26 | 3.6 | 3.6 | signal |
| 104 | Drug Intolerance | 79 | 3.6 | 3.6 | signal |
| 105 | Blood Pressure Increased | 124 | 3.5 | 3.6 | signal |
| 106 | Ventricular Fibrillation | 9 | 3.5 | 3.5 | signal |
| 107 | Nightmare | 28 | 3.5 | 3.5 | signal |
| 108 | Abnormal Behaviour | 32 | 3.5 | 3.5 | signal |
| 109 | Orthostatic Hypotension | 14 | 3.5 | 3.5 | signal |
| 110 | Thinking Abnormal | 15 | 3.5 | 3.5 | signal |
| 111 | Rebound Effect | 9 | 3.4 | 3.4 | signal |
| 112 | Therapeutic Product Effect Decreased | 35 | 3.4 | 3.4 | signal |
| 113 | Osteopenia | 12 | 3.4 | 3.4 | signal |
| 114 | Blood Pressure Decreased | 52 | 3.4 | 3.4 | signal |
| 115 | Poor Quality Product Administered | 8 | 3.4 | 3.4 | signal |
| 116 | Intervertebral Disc Protrusion | 17 | 3.4 | 3.4 | signal |
| 117 | Movement Disorder | 25 | 3.4 | 3.4 | signal |
| 118 | Mood Altered | 21 | 3.4 | 3.4 | signal |
| 119 | Pneumonia Aspiration | 19 | 3.3 | 3.3 | signal |
| 120 | Balance Disorder | 66 | 3.3 | 3.3 | signal |
| 121 | Iron Deficiency Anaemia | 7 | 3.3 | 3.3 | signal |
| 122 | Blood Lactate Dehydrogenase Increased | 12 | 3.3 | 3.3 | signal |
| 123 | Nervousness | 39 | 3.2 | 3.2 | signal |
| 124 | Type 2 Diabetes Mellitus | 25 | 3.2 | 3.2 | signal |
| 125 | Pericardial Effusion | 17 | 3.2 | 3.2 | signal |
| 126 | Ocular Discomfort | 8 | 3.2 | 3.2 | signal |
| 127 | Blood Urine Present | 14 | 3.2 | 3.2 | signal |
| 128 | Generalised Tonic-clonic Seizure | 12 | 3.2 | 3.2 | signal |
| 129 | Hernia | 14 | 3.2 | 3.2 | signal |
| 130 | Cyst | 9 | 3.1 | 3.1 | signal |
| 131 | Gamma-glutamyltransferase Increased | 16 | 3.1 | 3.1 | signal |
| 132 | Ear Pain | 14 | 3.1 | 3.1 | signal |
| 133 | Dyspnoea Exertional | 27 | 3.1 | 3.1 | signal |
| 134 | Tendonitis | 11 | 3.1 | 3.1 | signal |
| 135 | Erectile Dysfunction | 18 | 3.0 | 3.0 | signal |
| 136 | Cardiac Failure | 56 | 3.0 | 3.0 | signal |
| 137 | Skin Discolouration | 32 | 3.0 | 3.0 | signal |
| 138 | Hyperthyroidism | 10 | 3.0 | 3.0 | signal |
| 139 | Premature Delivery | 11 | 3.0 | 3.0 | signal |
| 140 | Laboratory Test Abnormal | 20 | 2.9 | 2.9 | signal |
| 141 | Dermatitis | 14 | 2.9 | 2.9 | signal |
| 142 | Stevens-johnson Syndrome | 15 | 2.9 | 2.9 | signal |
| 143 | Peripheral Swelling | 103 | 2.9 | 3.0 | signal |
| 144 | Delirium | 23 | 2.9 | 2.9 | signal |
| 145 | Amenorrhoea | 11 | 2.9 | 2.9 | signal |
| 146 | Angina Pectoris | 19 | 2.9 | 2.9 | signal |
| 147 | Joint Injury | 14 | 2.8 | 2.8 | signal |
| 148 | Memory Impairment | 90 | 2.8 | 2.9 | signal |
| 149 | Peripheral Coldness | 9 | 2.8 | 2.8 | signal |
| 150 | Menorrhagia | 13 | 2.8 | 2.8 | signal |
| 151 | Injection Site Mass | 24 | 2.8 | 2.8 | signal |
| 152 | Economic Problem | 10 | 2.8 | 2.8 | signal |
| 153 | Drug Dispensing Error | 10 | 2.8 | 2.8 | signal |
| 154 | Treatment Noncompliance | 35 | 2.8 | 2.8 | signal |
| 155 | Aggression | 32 | 2.8 | 2.8 | signal |
| 156 | Injection Site Nodule | 7 | 2.8 | 2.8 | signal |
| 157 | Squamous Cell Carcinoma | 6 | 2.8 | 2.8 | signal |
| 158 | Gait Inability | 21 | 2.8 | 2.8 | signal |
| 159 | Dental Caries | 7 | 2.7 | 2.7 | signal |
| 160 | Foot Deformity | 7 | 2.7 | 2.7 | signal |
| 161 | Lethargy | 36 | 2.7 | 2.7 | signal |
| 162 | Stress | 45 | 2.7 | 2.7 | signal |
| 163 | Interstitial Lung Disease | 30 | 2.7 | 2.7 | signal |
| 164 | Sensory Disturbance | 10 | 2.7 | 2.7 | signal |
| 165 | Apathy | 9 | 2.7 | 2.7 | signal |
| 166 | Anger | 21 | 2.7 | 2.7 | signal |
| 167 | Brain Fog | 9 | 2.7 | 2.7 | signal |
| 168 | Gallbladder Disorder | 11 | 2.7 | 2.7 | signal |
| 169 | Product Dose Omission Issue | 174 | 2.6 | 2.7 | signal |
| 170 | Drug Ineffective For Unapproved Indication | 34 | 2.6 | 2.7 | signal |
| 171 | Acute Myocardial Infarction | 18 | 2.6 | 2.6 | signal |
| 172 | Pulmonary Congestion | 8 | 2.6 | 2.6 | signal |
| 173 | Eyelid Ptosis | 6 | 2.6 | 2.6 | signal |
| 174 | Gait Disturbance | 113 | 2.6 | 2.6 | signal |
| 175 | Musculoskeletal Pain | 31 | 2.5 | 2.6 | signal |
| 176 | Condition Aggravated | 175 | 2.5 | 2.6 | signal |
| 177 | Central Nervous System Lesion | 8 | 2.5 | 2.5 | signal |
| 178 | Weight Fluctuation | 6 | 2.5 | 2.5 | no signal |
| 179 | Aphonia | 8 | 2.5 | 2.5 | signal |
| 180 | Dysuria | 21 | 2.5 | 2.5 | signal |
| 181 | Joint Dislocation | 6 | 2.5 | 2.5 | no signal |
| 182 | Anxiety | 161 | 2.4 | 2.5 | signal |
| 183 | Sudden Death | 6 | 2.4 | 2.4 | no signal |
| 184 | Disease Progression | 66 | 2.4 | 2.4 | signal |
| 185 | Blood Cholesterol Increased | 26 | 2.4 | 2.4 | signal |
| 186 | Paralysis | 8 | 2.4 | 2.4 | signal |
| 187 | Abdominal Pain Lower | 14 | 2.4 | 2.4 | signal |
| 188 | Anosmia | 8 | 2.4 | 2.4 | signal |
| 189 | Back Disorder | 9 | 2.4 | 2.4 | signal |
| 190 | Drug Exposure During Pregnancy | 19 | 2.4 | 2.4 | signal |
| 191 | Hypokinesia | 8 | 2.4 | 2.4 | signal |
| 192 | Crying | 20 | 2.4 | 2.4 | signal |
| 193 | Illness | 55 | 2.4 | 2.4 | signal |
| 194 | Exposure During Pregnancy | 34 | 2.4 | 2.4 | signal |
| 195 | Arrhythmia | 26 | 2.4 | 2.4 | signal |
| 196 | Abdominal Pain Upper | 112 | 2.4 | 2.4 | signal |
| 197 | Headache | 339 | 2.3 | 2.4 | signal |
| 198 | Vertigo | 33 | 2.3 | 2.4 | signal |
| 199 | Blood Glucose Abnormal | 10 | 2.3 | 2.3 | signal |
| 200 | Haematotoxicity | 5 | 2.3 | 2.3 | no signal |
| 201 | Skin Infection | 6 | 2.3 | 2.3 | no signal |
| 202 | Mental Impairment | 13 | 2.3 | 2.3 | signal |
| 203 | Overdose | 115 | 2.3 | 2.3 | signal |
| 204 | Abortion Induced | 5 | 2.3 | 2.3 | no signal |
| 205 | Scab | 6 | 2.3 | 2.3 | no signal |
| 206 | Bone Pain | 31 | 2.3 | 2.3 | signal |
| 207 | Fracture | 10 | 2.3 | 2.3 | signal |
| 208 | Rhinorrhoea | 34 | 2.3 | 2.3 | signal |
| 209 | Hyperhidrosis | 68 | 2.3 | 2.3 | signal |
| 210 | Posterior Reversible Encephalopathy Syndrome | 5 | 2.3 | 2.3 | no signal |
| 211 | Haematuria | 18 | 2.3 | 2.3 | signal |
| 212 | Metrorrhagia | 9 | 2.3 | 2.3 | signal |
| 213 | Glaucoma | 10 | 2.2 | 2.3 | signal |
| 214 | Vaginal Haemorrhage | 22 | 2.2 | 2.2 | signal |
| 215 | Musculoskeletal Chest Pain | 8 | 2.2 | 2.2 | signal |
| 216 | Speech Disorder | 27 | 2.2 | 2.2 | signal |
| 217 | Pulmonary Oedema | 23 | 2.2 | 2.2 | signal |
| 218 | Visual Impairment | 63 | 2.2 | 2.2 | signal |
| 219 | Decreased Immune Responsiveness | 5 | 2.2 | 2.2 | no signal |
| 220 | Inappropriate Schedule Of Product Administration | 90 | 2.2 | 2.2 | signal |
| 221 | Covid-19 | 90 | 2.2 | 2.2 | signal |
| 222 | Visual Acuity Reduced | 17 | 2.2 | 2.2 | signal |
| 223 | Blood Pressure Abnormal | 10 | 2.2 | 2.2 | signal |
| 224 | Disorientation | 20 | 2.2 | 2.2 | signal |
| 225 | Ulcer | 8 | 2.2 | 2.2 | no signal |
| 226 | Salivary Hypersecretion | 5 | 2.2 | 2.2 | no signal |
| 227 | Application Site Pain | 11 | 2.2 | 2.2 | signal |
| 228 | Taste Disorder | 10 | 2.2 | 2.2 | signal |
| 229 | Bursitis | 6 | 2.2 | 2.2 | no signal |
| 230 | Ovarian Cyst | 5 | 2.2 | 2.2 | no signal |
| 231 | Motor Dysfunction | 5 | 2.1 | 2.1 | no signal |
| 232 | Dry Throat | 5 | 2.1 | 2.1 | no signal |
| 233 | Cardiogenic Shock | 7 | 2.1 | 2.1 | no signal |
| 234 | Bronchospasm | 7 | 2.1 | 2.1 | no signal |
| 235 | Subdural Haematoma | 7 | 2.1 | 2.1 | no signal |
| 236 | Malaise | 214 | 2.1 | 2.2 | signal |
| 237 | Euphoric Mood | 5 | 2.1 | 2.1 | no signal |
| 238 | Libido Decreased | 6 | 2.1 | 2.1 | no signal |
| 239 | Dysarthria | 18 | 2.1 | 2.1 | signal |
| 240 | Nasal Congestion | 28 | 2.1 | 2.1 | signal |
| 241 | Skin Lesion | 13 | 2.1 | 2.1 | signal |
| 242 | Incorrect Route Of Product Administration | 8 | 2.1 | 2.1 | no signal |
| 243 | Immunodeficiency | 7 | 2.1 | 2.1 | no signal |
| 244 | Therapeutic Response Shortened | 15 | 2.0 | 2.0 | signal |
| 245 | Panic Attack | 17 | 2.0 | 2.0 | signal |
| 246 | Musculoskeletal Discomfort | 8 | 2.0 | 2.0 | no signal |
| 247 | Product Prescribing Error | 11 | 2.0 | 2.0 | signal |
| 248 | Disturbance In Attention | 25 | 2.0 | 2.0 | signal |
| 249 | Back Injury | 5 | 2.0 | 2.0 | no signal |
| 250 | Fall | 153 | 2.0 | 2.0 | no signal |
| 251 | Product Dispensing Error | 10 | 2.0 | 2.0 | no signal |
| 252 | Anorexia | 6 | 2.0 | 2.0 | no signal |
| 253 | Dysmenorrhoea | 6 | 2.0 | 2.0 | no signal |
| 254 | Hand Deformity | 6 | 2.0 | 2.0 | no signal |
| 255 | Pollakiuria | 19 | 2.0 | 2.0 | no signal |
| 256 | Road Traffic Accident | 19 | 2.0 | 2.0 | no signal |
| 257 | Diabetes Mellitus Inadequate Control | 8 | 2.0 | 2.0 | no signal |
| 258 | Rash Erythematous | 21 | 1.9 | 1.9 | no signal |
| 259 | Pancreatitis Acute | 10 | 1.9 | 1.9 | no signal |
| 260 | Activities Of Daily Living Impaired | 9 | 1.9 | 1.9 | no signal |
| 261 | Sinus Congestion | 6 | 1.9 | 1.9 | no signal |
| 262 | Foetal Exposure During Pregnancy | 36 | 1.9 | 1.9 | no signal |
| 263 | Pelvic Pain | 8 | 1.9 | 1.9 | no signal |
| 264 | Paraesthesia | 69 | 1.9 | 1.9 | no signal |
| 265 | Feeling Abnormal | 105 | 1.9 | 1.9 | no signal |
| 266 | Retinal Detachment | 4 | 1.9 | 1.9 | no signal |
| 267 | Nerve Compression | 4 | 1.9 | 1.9 | no signal |
| 268 | Therapeutic Response Decreased | 26 | 1.9 | 1.9 | no signal |
| 269 | Tooth Loss | 9 | 1.9 | 1.9 | no signal |
| 270 | Middle Insomnia | 8 | 1.9 | 1.9 | no signal |
| 271 | Depression | 98 | 1.9 | 1.9 | no signal |
| 272 | Metastases To Bone | 7 | 1.9 | 1.9 | no signal |
| 273 | Blood Test Abnormal | 6 | 1.9 | 1.9 | no signal |
| 274 | Carpal Tunnel Syndrome | 6 | 1.9 | 1.9 | no signal |
| 275 | Eye Disorder | 14 | 1.9 | 1.9 | no signal |
| 276 | Madarosis | 5 | 1.9 | 1.9 | no signal |
| 277 | Increased Appetite | 8 | 1.8 | 1.8 | no signal |
| 278 | Disseminated Intravascular Coagulation | 6 | 1.8 | 1.8 | no signal |
| 279 | Eye Inflammation | 4 | 1.8 | 1.8 | no signal |
| 280 | Blood Glucose Increased | 80 | 1.8 | 1.8 | no signal |
| 281 | Disease Recurrence | 20 | 1.8 | 1.8 | no signal |
| 282 | Emotional Disorder | 13 | 1.8 | 1.8 | no signal |
| 283 | Irritability | 25 | 1.8 | 1.8 | no signal |
| 284 | Face Oedema | 7 | 1.8 | 1.8 | no signal |
| 285 | Mood Swings | 13 | 1.8 | 1.8 | no signal |
| 286 | Fear | 11 | 1.8 | 1.8 | no signal |
| 287 | Secretion Discharge | 5 | 1.8 | 1.8 | no signal |
| 288 | No Therapeutic Response | 5 | 1.8 | 1.8 | no signal |
| 289 | Drug Effect Decreased | 22 | 1.7 | 1.7 | no signal |
| 290 | Metastases To Liver | 7 | 1.7 | 1.7 | no signal |
| 291 | Abasia | 10 | 1.7 | 1.7 | no signal |
| 292 | Hypoacusis | 17 | 1.7 | 1.7 | no signal |
| 293 | Hip Arthroplasty | 6 | 1.7 | 1.7 | no signal |
| 294 | Sluggishness | 4 | 1.7 | 1.7 | no signal |
| 295 | Injection Site Discomfort | 4 | 1.7 | 1.7 | no signal |
| 296 | Haematoma | 10 | 1.7 | 1.7 | no signal |
| 297 | Renal Pain | 4 | 1.6 | 1.6 | no signal |
| 298 | Impaired Work Ability | 8 | 1.6 | 1.6 | no signal |
| 299 | Hot Flush | 28 | 1.6 | 1.6 | no signal |
| 300 | Suicidal Ideation | 34 | 1.6 | 1.6 | no signal |
| 301 | Akathisia | 5 | 1.6 | 1.6 | no signal |
| 302 | Serotonin Syndrome | 7 | 1.6 | 1.6 | no signal |
| 303 | Red Blood Cell Sedimentation Rate Increased | 4 | 1.6 | 1.6 | no signal |
| 304 | Medication Error | 20 | 1.6 | 1.6 | no signal |
| 305 | Drug Prescribing Error | 7 | 1.6 | 1.6 | no signal |
| 306 | Blindness Unilateral | 5 | 1.5 | 1.5 | no signal |
| 307 | Status Epilepticus | 4 | 1.5 | 1.5 | no signal |
| 308 | Myocarditis | 4 | 1.5 | 1.5 | no signal |
| 309 | Eye Swelling | 13 | 1.5 | 1.5 | no signal |
| 310 | Anaphylactic Shock | 9 | 1.5 | 1.5 | no signal |
| 311 | Spinal Fracture | 7 | 1.5 | 1.5 | no signal |
| 312 | Product Substitution Issue | 20 | 1.5 | 1.5 | no signal |
| 313 | Impaired Quality Of Life | 5 | 1.5 | 1.5 | no signal |
| 314 | Pulmonary Arterial Hypertension | 5 | 1.5 | 1.5 | no signal |
| 315 | Injection Site Haematoma | 5 | 1.5 | 1.5 | no signal |
| 316 | Injection Site Warmth | 7 | 1.5 | 1.5 | no signal |
| 317 | Injection Site Pain | 102 | 1.5 | 1.5 | no signal |
| 318 | Product Dose Omission In Error | 9 | 1.5 | 1.5 | no signal |
| 319 | Thyroid Cancer | 4 | 1.4 | 1.4 | no signal |
| 320 | Bone Loss | 5 | 1.4 | 1.4 | no signal |
| 321 | Surgery | 19 | 1.4 | 1.4 | no signal |
| 322 | Hepatic Cytolysis | 4 | 1.4 | 1.4 | no signal |
| 323 | Gastrointestinal Carcinoma | 3 | 1.4 | 1.4 | no signal |
| 324 | Increased Tendency To Bruise | 3 | 1.4 | 1.4 | no signal |
| 325 | Respiratory Arrest | 9 | 1.4 | 1.4 | no signal |
| 326 | Product Packaging Issue | 3 | 1.4 | 1.4 | no signal |
| 327 | Injection Site Discolouration | 4 | 1.4 | 1.4 | no signal |
| 328 | Cardiac Disorder | 30 | 1.4 | 1.4 | no signal |
| 329 | Injection Site Swelling | 24 | 1.4 | 1.4 | no signal |
| 330 | Pharmaceutical Product Complaint | 8 | 1.3 | 1.3 | no signal |
| 331 | Pericarditis | 5 | 1.3 | 1.3 | no signal |
| 332 | Sars-cov-2 Test Positive | 4 | 1.3 | 1.3 | no signal |
| 333 | Hunger | 4 | 1.3 | 1.3 | no signal |
| 334 | Intentional Self-injury | 6 | 1.3 | 1.3 | no signal |
| 335 | Pregnancy | 6 | 1.3 | 1.3 | no signal |
| 336 | Coronary Artery Occlusion | 4 | 1.3 | 1.3 | no signal |
| 337 | Product Odour Abnormal | 3 | 1.3 | 1.3 | no signal |
| 338 | Syringe Issue | 5 | 1.2 | 1.2 | no signal |
| 339 | Suicide Attempt | 17 | 1.2 | 1.2 | no signal |
| 340 | Dry Skin | 36 | 1.2 | 1.2 | no signal |
| 341 | Meningioma | 4 | 1.2 | 1.2 | no signal |
| 342 | Product Availability Issue | 6 | 1.2 | 1.2 | no signal |
| 343 | Drug Dependence | 43 | 1.1 | 1.1 | no signal |
| 344 | Inappropriate Schedule Of Drug Administration | 19 | 1.1 | 1.1 | no signal |
| 345 | Injection Site Erythema | 32 | 1.1 | 1.1 | no signal |
| 346 | Acute Myeloid Leukaemia | 4 | 1.1 | 1.1 | no signal |
| 347 | Abnormal Dreams | 7 | 1.1 | 1.1 | no signal |
| 348 | Expired Product Administered | 8 | 1.0 | 1.0 | no signal |
| 349 | Poisoning | 3 | 1.0 | 1.0 | no signal |
| 350 | Tuberculosis | 3 | 1.0 | 1.0 | no signal |
| 351 | Injection Site Bruising | 18 | 1.0 | 1.0 | no signal |
| 352 | Menstruation Irregular | 6 | 1.0 | 1.0 | no signal |
| 353 | Hair Texture Abnormal | 3 | 1.0 | 1.0 | no signal |
| 354 | Drug Toxicity | 3 | 0.9 | 0.9 | no signal |
| 355 | Prostatic Specific Antigen Increased | 3 | 0.9 | 0.9 | no signal |
| 356 | Hepatocellular Injury | 3 | 0.9 | 0.9 | no signal |
| 357 | Acne | 16 | 0.9 | 0.9 | no signal |
| 358 | Emotional Distress | 25 | 0.9 | 0.9 | no signal |
| 359 | Product Quality Issue | 27 | 0.9 | 0.9 | no signal |
| 360 | Extrapyramidal Disorder | 5 | 0.9 | 0.9 | no signal |
| 361 | Incorrect Product Administration Duration | 4 | 0.9 | 0.9 | no signal |
| 362 | Product Dose Omission | 13 | 0.9 | 0.9 | no signal |
| 363 | Gynaecomastia | 6 | 0.8 | 0.8 | no signal |
| 364 | Drug Effect Incomplete | 7 | 0.8 | 0.8 | no signal |
| 365 | Injection Site Haemorrhage | 14 | 0.8 | 0.8 | no signal |
| 366 | Injection Site Reaction | 12 | 0.8 | 0.8 | no signal |
| 367 | Drug Effective For Unapproved Indication | 5 | 0.7 | 0.7 | no signal |
| 368 | Withdrawal Syndrome | 7 | 0.7 | 0.7 | no signal |
| 369 | Injection Site Pruritus | 11 | 0.7 | 0.7 | no signal |
| 370 | Product Administered At Inappropriate Site | 3 | 0.7 | 0.7 | no signal |
| 371 | Prostate Cancer | 11 | 0.6 | 0.6 | no signal |
| 372 | Application Site Pruritus | 3 | 0.6 | 0.6 | no signal |
| 373 | Injection Site Rash | 4 | 0.6 | 0.6 | no signal |
| 374 | Intentional Overdose | 8 | 0.5 | 0.5 | no signal |
| 375 | Injection Site Urticaria | 3 | 0.5 | 0.5 | no signal |
| 376 | Application Site Erythema | 3 | 0.5 | 0.5 | no signal |
| 377 | Incorrect Route Of Drug Administration | 4 | 0.5 | 0.5 | no signal |
| 378 | Breast Cancer | 10 | 0.5 | 0.5 | no signal |
| 379 | Product Storage Error | 9 | 0.5 | 0.4 | no signal |
| 380 | Pancreatic Carcinoma | 3 | 0.4 | 0.4 | no signal |
| 381 | Device Breakage | 4 | 0.4 | 0.4 | no signal |
| 382 | Device Dislocation | 4 | 0.4 | 0.4 | no signal |
| 383 | Device Expulsion | 6 | 0.4 | 0.4 | no signal |
| 384 | Device Issue | 8 | 0.4 | 0.4 | no signal |
| 385 | Dependence | 5 | 0.4 | 0.4 | no signal |
| 386 | Wrong Technique In Device Usage Process | 4 | 0.4 | 0.4 | no signal |
| 387 | Drug Dose Omission By Device | 5 | 0.3 | 0.3 | no signal |